Approval · Notice of Compliance 13079 · 2012
SUROLAN: Notice of Compliance 13079
Issued March 6, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13079
- Date
- March 6, 2012
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Antifungal, Antibacterial, Anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUROLAN | 00755753 | Marketed |
Medicinal ingredients
- MICONAZOLE NITRATE 23 MG per ML
- PREDNISOLONE ACETATE 5 MG per ML
- POLYMYXIN B SULFATE 0.5293 MG per ML